Xeris Biopharma Holdings Inc Revenue per Employee (XERS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 28.74% in the second quarter 2026, year on year to cumulative value of $335 million, Xeris Biopharma Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 5,160,215, this marks a new company high.
Within the Healthcare sector Employees of 7 other companies have achieved higher revenue per employee. While Xeris Biopharma Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 141 to 191. Xeris Biopharma Holdings Inc has 65 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 28.74 % 38.27 % 42.78 % 37.06 % 48.84 %
Sales per Employee (TTM) $ 5,160,215 4,843,892 4,489,923 4,094,415 3,785,000
XERS's Total Ranking # 191 # 141 # 197 # 200 # 227
Seq. Revenue Change 10.79 % -3.12 % 15.36 % 3.97 % 19 %

XERS Company Profile >> Back to XERS Efficiency Comparisons >> Compare XERS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 8
Overall Market # 191

Revenue per Employee Statistics
High Average Low
$ 5,160,215 $ 1,942,548 $ 1,462
(Jun 30 2026)   (Sep 30 2019)



Financial Statements
Xeris Biopharma Holdings Inc 's Revenue MRQ $ 92 Millions Visit XERS's Income Statement
Xeris Biopharma Holdings Inc 's Revenues TTM $ 335 Millions Visit XERS's aggregate revenue growth
What are XERS's Sales? Visit XERS's Sales by Segment




Other Ratios
Xeris Biopharma Holdings Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XERS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XERS's Competitors
Revenue per Employee for XERS's Suppliers
Revenue per Employee for XERS's Customers

You may also want to know
XERS's Sales Growth Rates XERS's Pe Price to earnings ratio XERS's Receivables Turnover Ratio XERS's Stock Quote
XERS's Net Income Growth Rates XERS's Ps Price to Sales ratio XERS's Sales per Employee XERS's Asset Turnover Ratio
XERS's Net Margin XERS's Pb Price to Book ratio XERS's Financial Strength Ratios XERS's Dividend Payout Ratio
Date modified: 2026-09-05T15:41:01+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Agilon Health Inc   6,915,905.37 $ 5,920.015  Million 856 
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.